La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Indans (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Indans (pharmacology) < Indans (therapeutic use) < Indazoles (pharmacology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000347 (2003) Olivier Rascol [France]Monoamine oxidase inhibitors--is it time to up the TEMPO?
000553 (2005) Olivier Rascol [France]Rasagiline in the pharmacotherapy of Parkinson's disease--a review.
000597 (2006) Joumana Hudry [France] ; Juha O. Rinne ; Tapani Ker Nen ; Laurent Eckert ; John M. CochranCost-utility model of rasagiline in the treatment of advanced Parkinson's disease in Finland.
000683 (2006) Rasagiline. Parkinson's disease: a simple me-too.
000775 (2007) Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
000C97 (2011) Santiago Perez-Lloret [France] ; Olivier RascolSafety of rasagiline for the treatment of Parkinson's disease.
000D04 (2011) Olivier Rascol [France] ; Cheryl J. Fitzer-Attas ; Robert Hauser ; Joseph Jankovic [États-Unis] ; Anthony Lang ; J William Langston ; Eldad Melamed ; Werner Poewe [Autriche] ; Fabrizio Stocchi ; Eduardo Tolosa ; Eli Eyal ; Yoni M. Weiss ; C Warren OlanowA double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
000F66 (2012) Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. MolineDonepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
001101 (2013) Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François TisonEncephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
001371 (2014) P. Cesaro [France] ; L. Defebvre [France][Drug treatment of early-stage (de novo and "honeymoon") Parkinson disease].
001835 (2015) Romain Lefaucheur [France] ; Floriane Le Goff [France] ; Gaëlle Gaillon [France] ; Aude Triquenot-Bagan [France] ; David Maltête [France]Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Indans (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Indans (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Indans (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024